Relmada Therapeutics Ownership | Who Owns Relmada Therapeutics?
Relmada Therapeutics Ownership Summary
Relmada Therapeutics is owned by 17.73% institutional investors, 8.04% insiders, and 74.23% retail investors. Franklin resources is the largest institutional shareholder, holding 4.32% of RLMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Relmada Therapeutics shares.
RLMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relmada Therapeutics | 17.73% | 8.04% | 74.23% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
| Idea | Psychedelic Stocks List | 21.13% | 12.05% | 66.82% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Franklin resources | 1.30M | 4.32% | $677.12K |
| Vanguard group | 1.26M | 4.16% | $653.49K |
| Acadian asset management | 1.23M | 4.07% | $636.00K |
| Blackrock funding, inc. /de | 593.33K | 1.97% | $308.53K |
| Blackrock | 573.31K | 1.90% | $1.72M |
| Palo alto investors lp | 495.15K | 1.64% | $257.48K |
| Geode capital management | 302.84K | 1.00% | $157.52K |
| Deutsche bank ag\ | 224.85K | 0.75% | $116.92K |
| Ubs group | 215.14K | 0.71% | $111.87K |
| Advisorshares investments | 210.07K | 0.70% | $109.23K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Spotlight asset group | 20.00K | 0.04% | $60.00K |
| Palo alto investors lp | 495.15K | 0.04% | $257.48K |
| Rosalind advisors | 100.00K | 0.03% | $52.00K |
| Advisorshares investments | 210.07K | 0.02% | $109.23K |
| Apricus wealth | 48.96K | 0.02% | $25.46K |
| Tang capital management | 200.82K | 0.01% | $104.43K |
| Gsa capital partners llp | 124.77K | 0.00% | $65.00K |
| Parsons capital management inc/ri | 163.34K | 0.00% | $84.94K |
| Beaumont capital management | 11.01K | 0.00% | $5.72K |
| Bedel financial consulting | 10.00K | 0.00% | $30.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tang capital management | 200.82K | 0.01% | 150.00K |
| Advisorshares investments | 210.07K | 0.02% | 141.54K |
| Renaissance | 164.51K | 0.00% | 138.63K |
| Rosalind advisors | 100.00K | 0.03% | 100.00K |
| Ubs group | 215.14K | - | 88.75K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Parsons capital management inc/ri | 163.34K | 0.00% | -839.36K |
| Deep track capital, lp | - | - | -674.83K |
| Vestal point capital, lp | - | - | -490.00K |
| Opaleye management | - | - | -480.00K |
| Jpmorgan chase | 37.70K | - | -277.36K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Rosalind advisors | 100.00K | 0.03% | 100.00K | $52.00K |
| Robertson stephens wealth management | 25.00K | 0.00% | 25.00K | $13.00K |
| Beaumont capital management | 11.01K | 0.00% | 11.01K | $5.72K |
| Bnp paribas arbitrage, snc | 72.00 | - | 72.00 | $37.00 |
Sold Out
| Holder | Change |
|---|---|
| Blackston financial advisory group | -2.00 |
| Innealta capital | -5.00 |
| Front row advisors | -6.00 |
| Smartleaf asset management | -35.00 |
| Qube research | -56.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 20 | -73.68% | 5,351,011 | -56.77% | 17 | 1.05% | 6 | -70.00% | 8 | -68.00% |
| Sep 30, 2024 | 76 | -9.52% | 12,376,687 | -8.70% | 41 | 2.03% | 20 | -4.76% | 25 | -21.88% |
| Jun 30, 2024 | 83 | -15.31% | 13,556,139 | -5.26% | 44 | 1.99% | 21 | -48.78% | 31 | 24.00% |
| Mar 31, 2024 | 98 | 11.36% | 14,308,498 | 5.06% | 47 | 2.32% | 41 | 2.50% | 25 | 25.00% |
| Dec 31, 2023 | 88 | -2.22% | 13,619,817 | -9.16% | 45 | 1.82% | 40 | 90.48% | 20 | -50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 851.92K | 2.82% | - |
| Vanguard US Total Market Shares ETF | 851.92K | 2.57% | - |
| Franklin Biotechnology Discv A(acc)USD | 623.80K | 2.07% | -221.90K |
| Vanguard Institutional Extnd Mkt Idx Tr | 353.63K | 1.17% | - |
| Franklin Biotechnology Discovery A | 336.31K | 1.11% | -120.09K |
| AdvisorShares Psychedelics ETF | 276.51K | 0.83% | - |
| Horizons Psychedelic Stock ETF | 227.04K | 0.75% | -36.13K |
| Fidelity Extended Market Index | 151.47K | 0.46% | -965.00 |
| Bridgeway Ultra-Small Company | 100.18K | 0.33% | - |
| Fidelity Enhanced Small Cap ETF | 92.92K | 0.31% | 1.75K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 11, 2024 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $153.71K |
| Sep 09, 2024 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $150.62K |
| Sep 10, 2024 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $90.79K |
| Sep 09, 2024 | CASAMENTO CHARLES J | - | Buy | $33.28K |
| Sep 11, 2024 | Shenouda Maged | Chief Financial Officer | Buy | $71.15K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | 8 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | 9 | - |
| 2023 Q4 | - | - |
RLMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools